title: The cost-effectiveness of various modes of screening for primary open angle glaucoma.
abstract: Various modes of screening for glaucoma were defined in terms of different combinations of the three main tests (ophthalmoscopy (O), tonometry (T), and perimetry (P)), together with associated referral criteria. The number of referrals and true positives generated by each mode was estimated for a model population, which was distributed with respect to age, intraocular pressure (IOP), optic disc condition, visual field defects, family history of glaucoma, and myopic status, as indicated by epidemiological studies. The costs of primary examination, and also of the secondary examination of referrals, were estimated for each mode, thus enabling the total cost per true positive to be calculated (in Pound sterling at 1995 UK prices, subsequently converted to US dollars at Pound 1.00 = $1.55.) The modes using O and T routinely, with P either routinely or selectively on all glaucoma high-risk groups, were found to provide the best balance between sensitivity (> or = 80%) and cost per true positive. The latter was around $850 when the cost of ophthalmoscopy could be shared as part of a general eye examination. The calculations assumed a 0.6% prevalence of previously undetected glaucomas in the community: with higher prevalences, costs per true positive would be lower. Screening the 40-59 years age group was found to be about as economic as for older people, when life expectancy was taken into account. It was concluded that glaucoma screening of people over age 40 years could be justifiable, provided that it is worth more than about $850 to detect a new case. Whilst based on UK values, the analysis could be applied to different primary health care settings in other countries.
authors.affiliation: International Glaucoma Association, King's College Hospital, London, U.K.
authors.forename: M W
authors.initials: MW
authors.lastname: Tuck
authors.forename: R P
authors.initials: RP
authors.lastname: Crick
mesh_terms: D000293:Adolescent; D000328:Adult; D017677:Age Distribution; D000368:Aged; D002648:Child; D003362:Cost-Benefit Analysis; D004739:England / Q000453:epidemiology; D005902:Glaucoma, Open-Angle / Q000175:diagnosis* / Q000191:economics / Q000453:epidemiology; D006801:Humans; D007429:Intraocular Pressure; D008875:Middle Aged; D009887:Ophthalmoscopy / Q000191:economics; D011237:Predictive Value of Tests; D015995:Prevalence; D014065:Tonometry, Ocular / Q000191:economics; D015351:Vision Screening / Q000191:economics* / Q000379:methods; D058609:Visual Field Tests / Q000191:economics; D014794:Visual Fields